Scott E Berkowitz

22PUBLICATIONS
69CO-AUTHORS
Exercise physiologyPharmacogenomicsPhysiotherapyEpidemiology not elsewhere classifiedRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Feb 27, 2026
Low-Dose Rivaroxaban Plus Aspirin in Patients With PAD Undergoing Lower Extremity Revascularization With and Without History of Prior Limb Revascularization: Insight From the VOYAGER-PAD Trial.

Mario Enrico Canonico, Jessica Parr, E Sebastian Debus

|Oct 23, 2025
Rivaroxaban in Peripheral Artery Disease After Revascularization: Worst Events and Net Outcomes in VOYAGER PAD.

Shea Hogan, Michael Szarek, E Sebastian Debus

|Apr 30, 2025
Prescription of aspirin plus low-dose rivaroxaban in patients with peripheral artery disease after lower-extremity revascularization.

Mario Enrico Canonico, Connie N Hess, Sivan Naveh

|May 23, 2024
Assessment of Days Alive Out of Hospital as a Possible End Point in Trials of Stroke Prevention for Atrial Fibrillation: A ROCKET AF Analysis.

Josephine Harrington, Anne S Hellkamp, Kenneth W Mahaffey

|May 06, 2024
Low-Dose Rivaroxaban Plus Aspirin in Patients With Peripheral Artery Disease Undergoing Lower Extremity Revascularization With and Without Concomitant Coronary Artery Disease: Insights From VOYAGER PAD.

Justin T Morrison, Mario Enrico Canonico, Sonia S Anand

|Apr 02, 2024
Quantitative Benefit-Risk Evaluation of Rivaroxaban in Patients After Peripheral Arterial Revascularization: The VOYAGER PAD Trial.

Zhong Yuan, Bennett Levitan, Hsiaowei Deng

Pageof 4

Frequent Collaborators

12 joint publications

Marc P Bonaca

10 joint publications

Sonia S Anand

10 joint publications

Manesh R Patel

10 joint publications

Rupert M Bauersachs